Results 131 to 140 of about 15,470 (180)
Some of the next articles are maybe not open access.
The pathophysiology of hypophosphatemia
Best Practice and Research in Clinical Endocrinology and MetabolismAfter identification of fibroblast growth factor (FGF) 23 as the pivotal regulator of chronic serum inorganic phosphate (Pi) levels, the etiology of disorders causing hypophosphatemic rickets/osteomalacia has been clarified, and measurement of intact FGF23 serves as a potent tool for differential diagnosis of chronic hypophosphatemia.
Hajime Kato +2 more
exaly +3 more sources
Hypophosphatemia-induced Cardiomyopathy
American Journal of the Medical Sciences, 2016Relatively few studies have been conducted to evaluate the effect of hypophosphatemia on cardiac function. The goal of this review was to determine whether there is an association between hypophosphatemia and cardiac function and to increase awareness of hypophosphatemia-induced cardiomyopathy as a new clinical entity and a reversible cause of heart ...
Masayuki Nogi
exaly +3 more sources
AJN, American Journal of Nursing, 1985
info:eu-repo/semantics ...
Vincent, Jean Louis, Goldstein, Jacques
openaire +4 more sources
info:eu-repo/semantics ...
Vincent, Jean Louis, Goldstein, Jacques
openaire +4 more sources
Pediatric Nephrology, 2012
Over the last decade the discovery of fibroblast growth factor 23 (FGF23) and the progressive and ongoing clarification of its role in phosphate and mineral metabolism have led to expansion of the diagnostic spectrum of primary hypophosphatemic syndromes. This article focuses on the impairment of growth in these syndromes.
Fernando, Santos +5 more
openaire +2 more sources
Over the last decade the discovery of fibroblast growth factor 23 (FGF23) and the progressive and ongoing clarification of its role in phosphate and mineral metabolism have led to expansion of the diagnostic spectrum of primary hypophosphatemic syndromes. This article focuses on the impairment of growth in these syndromes.
Fernando, Santos +5 more
openaire +2 more sources
Drug Intelligence & Clinical Pharmacy, 1984
Hypophosphatemia, defined as serum phosphate levels <2.5 mg%, is a relatively common disorder that can affect virtually every organ system. Phosphate deficiency can result from decreases in phosphate intake or absorption, increased loss from renal and nonrenal pathways, and transcellular phosphate shifts.
openaire +2 more sources
Hypophosphatemia, defined as serum phosphate levels <2.5 mg%, is a relatively common disorder that can affect virtually every organ system. Phosphate deficiency can result from decreases in phosphate intake or absorption, increased loss from renal and nonrenal pathways, and transcellular phosphate shifts.
openaire +2 more sources
Endocrinology and Metabolism Clinics of North America, 1993
This article discusses the regulation of serum phosphorus under normal conditions, focusing on the pathophysiology of acquired hypophosphatemia and its clinical manifestation. In addition, the clinical settings and conditions in which hypophosphatemia is likely to cause severe morbidity are emphasized.
S F, Hodgson, D L, Hurley
openaire +2 more sources
This article discusses the regulation of serum phosphorus under normal conditions, focusing on the pathophysiology of acquired hypophosphatemia and its clinical manifestation. In addition, the clinical settings and conditions in which hypophosphatemia is likely to cause severe morbidity are emphasized.
S F, Hodgson, D L, Hurley
openaire +2 more sources
Hypophosphatemia in the Alcoholic
Archives of Internal Medicine, 1980Elsewhere in this issue (see p 673), Ryback and his associates confirm the common occurrence 1 of hypophosphatemia in hospitalized alcoholics. It is important to recognize this finding since either hypophosphatemia or phosphorus deficiency may play an important role in the morbidity of the long-term alcoholic. The ubiquitous, poorly nourished alcoholic
openaire +2 more sources
Hypophosphatemia in users of Cannabis
Journal of Kidney, 2017As cannabis use has legalized for medical and recreational use in several states, the medical community has become more aware of the drug's potential toxicities. First described in 2004, cannabinoid hyperemesis syndrome is increasingly recognized as a cause of hospitalization among drug users.
openaire +2 more sources
Treatment of Refractory Hypophosphatemia
Southern Medical Journal, 1982Profound hypophosphatemia developed in a patient with chronic alcoholism. Multiple causative factors were identified and were thought to account for the initial failure of phosphorus repletion. High-dose intravenous phosphorus was effective in restoring serum phosphorus to normal with no observable adverse effects.
D L, Andress, J B, Vannatta, R, Whang
openaire +2 more sources